At Verastem Oncology, we're advancing innovation and addressing the urgent needs of patients living with cancers driven by RAS/MAPK pathway mutations, a key driver of tumor growth and treatment resistance. The FDA approval of AVMAPKI FAKZYNJA CO-PACK delivered the first therapy specifically for women living with recurrent KRAS-mutated low-grade serous ovarian cancer, a rare cancer with significant unmet need. We’ve successfully launched this innovative combination therapy in the U.S. and are exploring regulatory pathways for Europe and Japan. We are continuing to advance our pipeline of drugs that we believe will help block cancer cell survival, inhibit tumor growth, and overcome treatment resistance. With clinical trials underway, we have an exciting opportunity to shape the future of cancer care and make a meaningful impact in the lives of patients. We are seeking a Scientific Director, Medical Affairs to lead various initiatives within the Medical Affairs organization for Verastem’s potentially best-in-class KRAS G12D ON/OFF inhibitor: VS-7375. Reporting to the Head of Medical Communications, this individual will drive the planning and development of medical communications including publications, field medical resources, and advisory board content. Additionally, this individual will partner cross functionally to facilitate the review of independent research proposals.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior